Journal
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
Volume 30, Issue 6, Pages 465-469Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.ijdevneu.2012.05.007
Keywords
Nifedipine; Nimodipine; Oxygen and glucose deprivation; PC12; Hypocampal slices; Neuroprotection
Categories
Funding
- David R. Bloom Center for Pharmacy at The Hebrew University of Jerusalem, Israel
Ask authors/readers for more resources
The goal of this study was to compare the neuroprotective properties of the L-type Ca2+ channel blockers, nimodipine and nifedipine, using nerve growth factor (NGF)-differentiated PC12 neuronal cultures exposed to oxygen-glucose deprivation (OGD) and trophic withdrawal-induced cell death. Nimodipine (1-100 mu M) conferred 65 +/- 13% neuroprotection upon exposure to OGD and 35 +/- 6% neuroprotection towards different trophic withdrawal-induced cell death measured by lactate dehydrogenase and caspase 3 activities. The time window of nimodipine conferred neuroprotection was detected during the first 5 h but not at longer OGD exposures. Nifedipine (1-100 mu M), to a lower potency than nimodipine, conferred 30-55 +/- 8% neuroprotection towards OGD in PC12 cells and 29 +/- 5% in rat hypocampal slices, and 10 +/- 3% neuroprotection at 100 mu M towards trophic withdrawal-induced PC12 cell death. The ability to demonstrate that nimodipine conferred neuroprotection in a narrow therapeutic time-window indicates that the OGD PC12 model mimics the in vivo models and therefore suitable for neuroprotective drug discovery and development. (C) 2012 ISDN. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available